Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin vs Ofloxacin for PID
NCT01241110Phase 4Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Jan 2010
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of azithromycin in pelvic inflammatory disease (PID) (2 arms), sponsored by Guilan University of Medical Sciences. Primary endpoints: Efficacy of oral antibiotic protocols at 10 days and Side effects of oral antibiotic protocols at 10 days. Started Jan 2010; status: completed.
02
Drugs
azithromycin
03
Conditions
pelvic inflammatory disease (PID)
Beyond the preview
Go deeper on NCT01241110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01241110.